retatrutide clinical trials safety efficacy Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Clinical trial for chronic obesity

This multi-dimensional therapeutic potential is reshaping the positioning of GLP-1 drugs as comprehensive metabolic treatments rather than just glucose-lowering agents For instance, Novo Nordisks semaglutide is now marketed as Wegovy specifically for chronic weight management, while Eli Lillys tirzepatide has received FDA approval under the brand name Zepbound for obesity treatment, independent of diabetic status

Stop settling for diluted hair serums

In schizophrenia, GLP-1 receptor agonists improve metabolic health but not core psychotic symptoms

Her medications included tirzepatide 2.5 mg subcutaneous once weekly, apixaban 5 mg twice daily, spironolactone 25 mg once daily, furosemide 20 mg once daily, atorvastatin 20 mg once daily, fluoxetine 30 mg once daily, lisinopril 2.5 mg once daily, and atenolol 37.5 mg once daily

I tried every diet out there and nothing stuck